Nanochon key facts
as of Oct 2026- Developer of a 3D-printed cartilage implant designed to replace damaged cartilage and promote new tissue growth.
- Nanochon is valued at approximately $29.0M as of Oct 2026, set at its seed round, Dec 2025; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $11.9M across 3 recorded rounds; the latest was Seed Round ($3.6M) in Dec 2025.
- Notable investors include Plug and Play Tech Center, Alumni Ventures, Creative Destruction Lab, US National Science Foundation, MassChallenge — 28 tracked in total.
- Nanochon has filed 3 Form Ds with the SEC since 2021, most recently May 2024 ($4.0M sold to 34 investors).
- Status: Privately Held (backing).
Valued at $29.0M at its seed round, Dec 2025. Nothing has traded since.
- ·The complete investor list: 28 names
- ·Watch Nanochon: the Monday email on marks, rounds and moves
Nanochon funding rounds
3 roundsWho backs Nanochon
28+Nanochon valuation
Nanochon was valued at $29 million at its seed round in Dec 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Nanochon raised?
Nanochon has raised $11.9 million across 3 recorded rounds since 2021. The largest was a $4 million seed round in Aug 2023; the most recent was a $3.6 million seed round in Dec 2025.
Nanochon has filed 3 Form Ds with the SEC since 2021, most recently in May 2024 ($4 million sold to 34 investors).
Nanochon investors
28 investors are on record for Nanochon, including Plug and Play Tech Center, Alumni Ventures, Creative Destruction Lab and US National Science Foundation. By type, the record holds 8 venture capital firms and 1 angel investor. The seed round in Dec 2025 drew 39 investors.
About Nanochon
Developer of a 3D-printed cartilage implant designed to replace damaged cartilage and promote new tissue growth. The company's devices replace lost or damaged cartilage and encourage new tissue growth, enabling medical practitioners to access cost-effective, on-demand devices that improve outcomes for young, active patients with knee damage.
- Sector
- Healthcare
- HQ
- Washington, DC, United States
- Founded
- 2013
- Employees
- 3
- Website
- nanochon.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.